Rashed Dewan

Director Financiero/CFO en PROFOUND MEDICAL CORP. .

Fortuna: 190 688 $ al 30/04/2024

56 años

Health Technology

Consumer Services

Cargos activos de Rashed Dewan

Empresas	Cargo	Inicio	Fin
PROFOUND MEDICAL CORP.	Director Financiero/CFO	03/03/2022	-
	Comptroller/Controller/Auditor	19/05/2021	03/03/2022
	Oficial de Recursos Humanos	-	03/03/2022
	Corporate Officer/Principal	03/05/2018	19/05/2021

Empresas	Cargo	Inicio	Fin
Profound Medical, Inc. Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada.	Comptroller/Controller/Auditor	06/07/2015	-

University of Southern California

Undergraduate Degree

Internacional

Canadá	3
Estados Unidos	2

Operativa

Comptroller/Controller/Auditor	2
Director of Finance/CFO	1
Human Resources Officer	1

Sectorial

Health Technology	3
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
PROFOUND MEDICAL CORP.	Health Technology

Empresas privadas	1
Profound Medical, Inc. Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada.	Health Technology

Empresas privadas

Health Technology